Skip to Main Content

Author Details

Jure Murgic
University Hospital Center Sestre Milosrdnice
2008
54
12
PMIDPaper TitleJournal TitlePublished Year
37414620Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.Clin Genitourin Cancer2023
37389960Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16.Biomol Biomed2023
32605887Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.Eur Urol Oncol2022
35718075A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.Pract Radiat Oncol2022
35778337Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
36938555ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER.Acta Clin Croat2022
36938553RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER.Acta Clin Croat2022
36938552MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.Acta Clin Croat2022
36938551DOSIMETRIC VERIFICATION OF INTENSITY MODULATED RADIOTHERAPY (IMRT) TREATMENT PLANS FOR PROSTATE CANCER PATIENTS.Acta Clin Croat2022
36155169Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.Clin Genitourin Cancer2022
35101189Radiation Therapy for Cure or Palliation: Case of the Immunosuppressed Patient With Multiple Primary Cancers and Liver Transplant.Int J Radiat Oncol Biol Phys2022
35205427Alpha Satellite RNA Levels Are Upregulated in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer.Genes (Basel)2022
35078711Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.Clin Genitourin Cancer2022
34597472Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.BJU Int2022
33423945A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.Eur Urol Oncol2021
33556233Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.BJU Int2021
34075770New Insights into the Diagnosis, Molecular Taxonomy, and Treatment of Bladder Cancer.Acta Med Acad2021
34075765Genetics of Prostate Carcinoma.Acta Med Acad2021
33989586In Regard to van Son et al.Int J Radiat Oncol Biol Phys2021
33980277Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.Radiat Oncol2021
32234933Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage.Anticancer Res2020
31971495Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.J Urol2020
32048930Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational Survey.JCO Oncol Pract2020
31829450Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.Cancer2020
33220228In Regard to Lee et al.Int J Radiat Oncol Biol Phys2020
31126856Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy.Brachytherapy2019
30170099Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy.Int J Radiat Oncol Biol Phys2019
29239812Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.Brachytherapy2018
30244878Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.Int J Radiat Oncol Biol Phys2018
29249526Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate Cancer.Int J Radiat Oncol Biol Phys2018
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
28434799Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy.Radiother Oncol2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
28848661Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?ESMO Open2017
26832674Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer.Brachytherapy2016
27843608Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP).ESMO Open2016
24064749Time to Nadir PSA: Of Popes and PSA--The Immortality Bias.Am J Clin Oncol2015
25550591Sunitinib-induced thyrotoxicosis - a not so rare entity.Anticancer Res2015
24922691Hypothyroidism as a predictive clinical marker of better treatment response to sunitinib therapy.Anticancer Res2014
24982415High-dose-rate brachytherapy and concurrent chemoradiotherapy followed by surgery for stage Ib-IIb cervical cancer: single institution experience.Anticancer Res2014
24987355Familial adenomatous polyposis in three generations of a single family: a case study.Case Rep Oncol2014
24842891Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.J Nucl Med2014
22522987Breast and gynecological cancers in Croatia, 1988-2008.Croat Med J2012
23390830Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.Coll Antropol2012
22852797The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer.Radiat Oncol2012
22816241Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer.Coll Antropol2012
21755735Postoperative use of radioiodine (131-I): review of recommendations and guidelines.Coll Antropol2011
22034781Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.Acta Clin Croat2011
21888085[Leiomyomatous renal cell carcinoma - case report].Lijec Vjesn2011
21755739Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature.Coll Antropol2011
  • 1 - 50 of 54

Recommended Authors

University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 15
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 4
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 9
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year 2010
Number of shared co-authors 21
University of Washington
Career Start Year 2010
Number of shared co-authors 6
University of California los angeles
Career Start Year 2008
Number of shared co-authors 13
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 12
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 6
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 6
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 4
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 12
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 10
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 7
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 16
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 6
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 19
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 10
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 11
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 12
University of California los angeles
Career Start Year 1996
Number of shared co-authors 8
Hospital Universitari Vall d'Hebron
Career Start Year 1994
Number of shared co-authors 3
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 4
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 7
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 4
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 4
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 9
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 12

Collaborators

University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 9
David Geffen School of Medicine at university of california los angeles
Co-authored papers 9
Co-authored papers 8
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 7
National Cancer Centre Singapore
Co-authored papers 7
University of Toronto
Co-authored papers 6
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
University Health Network, University of Toronto
Co-authored papers 4
University of California los angeles
Co-authored papers 4
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Princess Margaret Hospital, University of Toronto
Co-authored papers 4
Tufts University School of Medicine
Co-authored papers 3
University of Washington Medical Center
Co-authored papers 3
University Health Network
Co-authored papers 3
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 2
University Hospitals Bristol and Weston NHS Foundation Trust
Co-authored papers 2
University of Pennsylvania
Co-authored papers 2
UCSF Medical Center-Mount Zion
Co-authored papers 2
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 2
CHU de Quebec-Universite Laval
Co-authored papers 2
University of Toronto
Co-authored papers 2
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
CHU de Quebec-Universite Laval
Co-authored papers 2
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 2
Princess Margaret Cancer Center
Co-authored papers 2
University of Toronto
Co-authored papers 2
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 2